I will absolutely be back to buy more services in the near future
and Hospital, 11 Department of Gastroenterology, Sri Ramchandra Medical College and Hospital, Chennai, India, 12 Government Medical College, Thiruvananthapuram, 13 Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University-Varanasi, 14 Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India, 15 Institute of Liver and Biliary Sciences, 16 Department of Gastroenterology and Hepatology, Sir Gangaram Hospital, New Delhi, India, 17 Department of Hepatology, Jaslok Hospital, Mumbai, India, 18 Department of Gastroenterology and Hepatology, Sir Gangaram Hospital, New Delhi, India, 19 Department of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneshwar, 20 Department of Gastroenterology, Indira Gandhi Medical College & Hospital, Shimla, India, 21 Department of Gastroenterology and Hepatology, Amrita Institute of Medical Sciences, Kochi, India, 22 Department of Gastroenterology, SNMC Medical College, Jodhpur, India, 23 Department of Gastroenterology, SMS Medical College and Hospital, Jaipur, India, 24 Department of Gastroenterology, Apollo Multi-Speciality Hospital, Kolkata, India, 25 Department of Hepatology, Asian Institute of Gastroenterology, Hyderabad, India, 26 Seth GS Medical College & KEM Hospital, 27 Department of Medicine, NSC Bose Medical College and Hospital Jabalpur, India, 28 Department of Gastroenterology, AII India Institute of Medical Sciences Rishikesh, India, 29 Department of Hepatology, Max Hospital, Saket, New Delhi, 30 Madras Medical College, 31 Shree RB Shah Mahavir Superspeciality Hosptial, 32 Department of Gastroenterology, Guwahati Medical College and Hospital, Guwahati, India, 33 VGM Gastro Centre, Coimbatore, India, 34 Lakeshore Hospital, 35 Virginia Commonwealth University Background: The association between diabetes mellitus and liver fibrosis is well studied in patients with nonalcoholic fatty liver disease (NAFLD)
Peptide Stacking: Synergies with GLP-1s and Other Compounds A forward-looking area of clinical interest is the potential for a MOTS-c stack with other metabolic therapies
Morikis VA, Chase S, Wun T, Chaikof EL, Magnani JL, Simon SI
10.4103/0973-8258.120223 40 BirhanY
doi: 10.1378/chest.11-0047
